In 2030, U.S. mortality and morbidity rates will suddenly jump. This will happen not because there is a new pandemic or a ...
With research on abortion access barriers, STAT Wunderkind Betsy Pleasants is defining a framework for using AI tools without ...
As the midterm elections draw near, the MAHA movement is nearly invisible on the campaign trail and struggling to find a ...
The FDA flagged a potential safety signal after four patient deaths in a trial testing a schizophrenia drug, Argenx faces an unusual setback, and more pharma news.
The Trump administration wants to make three big changes to the U.S. Census, including eliminating questions about race, ...
How has the NIH been spending its budget? And why are biotech investors feeling gloomy? Find out on this week's episode of ...
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health ...
Basic studies led to clinical and translational advances that no one could have predicted,” Robert Gallo writes of his work ...
The Trump administration announced Thursday that it is investigating nine universities for alleged fraud related to visas ...
The FDA says its ongoing safety review of the nation's main abortion pill will continue into next year, a timeline that was ...
A new proposal in Congress to scrap a surprise billing ban’s controversial arbitration system will need to to survive an onslaught of attacks from provider groups.
There’s increasing evidence that older women with breast cancer could benefit from more tailored treatments. STAT Wunderkind ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results